Health Sciences Grants

Health Sciences Research Awards and Grants

Title Type $ Amount Activity Investigator Unit Sponsor Date
A Double-Blind, Active-Controlled, Multiple-Ascending Dose Phase 1b Study of Aerosolized RSP-1502 Delivered Via the PARI LC Plus Nebulizer in Subjects with Cystic Fibrosis and Chronic Pseudomonas aeru Contract 306,429.52 Clinical Trial Cori Daines Asthma/Airway Disease Rsch Ctr Respirion Pharmaceuticals Pty Ltd (Australia) 01/2024
A First-in-human (FIH) Study of Inhibitory Interneurons (NRTX-1001) in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE) Contract 749,783.32 Clinical Trial David Labiner Neurology Neurona Therapeutics 11/2023
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Ficlatuzumab in Combination with Cetuximab in Participants with Recurrent or Metastatic (R/M) HPV-Negative Head and Neck S Contract 119,770.80 Clinical Trial Ricklie Julian Cancer Center Division Aveo Pharmaceuticals Incorporated 02/2024
A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers Contract 509,763.60 Clinical Trial Rachna Shroff Cancer Center Division Compass Therapeutics 12/2023
A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo-Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of MK-5475 in Adults with Pulmonary Arterial Hypertension Contract 235,166.76 Clinical Trial Nafis Shamsid-Deen COM Phx Internal Medicine Merck Sharp & Dohme Corp. 11/2023
A Phase 2a, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ALT-100 in Patients With Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Contract 369,191.00 Clinical Trial Zachary Hernandez COM Phx Internal Medicine Novotech Clinical Research USA, LLC 11/2023
A Phase 3, Open-Label Study to Evaluate Safety and Efficacy of Epcoritamab in Combination with Rituximab and Lenalidomide (R2) Compared to R2 in Subjects with Relapsed or Refractory Follicular Lymphom Contract 1,246,360.61 Clinical Trial Abhijeet Kumar Cancer Center Division AbbVie Incorporated 02/2024
A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor Xla Inhibitor, for Stroke Prevention After an Acute Is Contract 341,296.28 Clinical Trial Firas Kaddouh Neurology IQVIA RDS Inc. 12/2023
A Phase 3, Randomized, Open-label Study to Evaluate Safety and Efficacy of Epcoritamab in Combination With R-CHOP Compared to R-CHOP in Subjects With Newly Diagnosed Diffuse Large B-cell Lymphoma (DLB Contract 1,097,975.93 Clinical Trial Abhijeet Kumar Cancer Center Division AbbVie Incorporated 11/2023
A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects with Moderate to Severe Hidradenitis Suppurativa Who Have Contract 964,023.30 Clinical Trial Daniel Butler Medicine AbbVie Incorporated 01/2024
A Phase 4, Global, Prospective, Open label Study of Ozanimod to Explore the Safety, Efficacy, Quality of Life, and Biomarker Response in Participants with Moderate to Severe Ulcerative Colitis in Clin Contract 169,895.50 Clinical Trial Sasha Taleban Medicine Celgene Corporation 11/2023
A Phase I/II, Randomized, Double-blind, Sham Control Study to Explore Safety, Tolerability, and Efficacy Signals of Multiple Ascending Doses of Striatally-Administered rAAV5-miHTT Total Huntingtin Gen Contract 1,091,512.00 Clinical Trial Paul Larson Neurosurgery UniQure 01/2024
A Phase III, Multicentre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tozorakimab (MEDI3506) in Patients Hospitalised for Viral Lung Infec Contract 1,286,672.52 Clinical Trial Christian Bime Medicine Astrazeneca 11/2023
A Randomized Controlled Trial to Evaluate the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose at Increased Risk of Liver Injury Contract 274,224.40 Clinical Trial Farshad Shirazi Dept of Emergency Medicine Denver Health and Hospital Authority 01/2024
A Registry Study for Subjects who Participated in AMBULATE DFU and AMBULATE DFU II. Contract 224,796.00 Clinical Trial Wei Zhou Surgery TissueTech, Inc 01/2024
Accelerated Insulin Absorption by Administration Through a Miniature Subcutaneously Implanted Vascularized Chamber Grant 99,360.00 Research Klearchos Papas Surgery Procyon Technologies, LLC 11/2023
Achieving Equity in Farmworker Health Through Community-Led Research Contract 445,438.00 Research Maia Ingram Health Promotion Sciences Campesinos Sin Fronteras 11/2023
An Interventional, Multi-Center Investigation of Single-Level Lumbar Interbody Fusion Stabilized With Pedicle Screws Contract 2,887,900.00 Clinical Trial Richard Chua Neurosurgery 3Spine Management Company, Inc. 11/2023
An Open Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of the Combination of Lasofoxifene and Abemaciclib to the Combination of Fulvestrant and Abemaciclib for the Treatment of Contract 342,906.20 Clinical Trial Jennifer Segar Cancer Center Division Medpace 12/2023
An Open-label Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis Contract 118,430.00 Clinical Trial Sachin Chaudhary Medicine United Therapeutics Corporation 11/2023